Document Detail

Radiosensitization of p53-Deficient Lung Cancer Cells by Pre-treatment with Cytostatic Compounds.
MedLine Citation:
PMID:  22493354     Owner:  NLM     Status:  In-Data-Review    
Background/Aim: This study specifies a strategy to improve radiotherapy by partial synchronization of p53-deficient cancer cells (FaDu and H1299) in mitosis using taxol, with protecting p53 wild-type cells (A549) by the prior administration of cytostatic compounds. Cytotoxic and cytostatic effects of ionizing radiation, cisplatin, doxorubicin and taxol, administrated alone or in combination were investigated in vitro by flow cytometry. RESULTS: A protective effect of doxorubicin but not cisplatin was found after administration of triple sequence with ionizing radiation and taxol. It was found that preliminary administration of doxorubicin induced growth arrest and protected A549 cells from the taxol/radiation treatment, while simultaneously killing FaDu and H1299 cells. CONCLUSION: The proposed therapeutic strategy allows protection of p53 wild-type cells and selectively increases radiosensitivity of p53-deficient cancer cells.
Sergey V Tokalov; Nasreddin Abolmaali
Related Documents :
10786694 - Insulin-like growth factor i receptor signaling in differentiation of neuronal h19-7 ce...
8382114 - Production of scatter factor-like activity by a nitrosamine-induced pancreatic cancer c...
9952474 - Separating growth from elastic deformation during cell enlargement
6380994 - The relative effects of different types of growth factors on dna replication, mitosis, ...
15928714 - Autophagy: dual roles in life and death?
9025914 - Quantification of cell-matrix and cell-cell adhesion using horseradish peroxidase.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-04-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  1239-43     Citation Subset:  IM    
Development and Regeneration Department, Foundation Caubet-CIMERA, Ctra. de Soller km 12, 071100 Bunyola, Ballearic Islands, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  COM-1/p8 Acts as a Tumour Growth Enhancer in Colorectal Cancer Cell Lines.
Next Document:  Molecular characterization of human cutaneous melanoma-derived cell lines.